Cargando…
Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases that are considered to be on the same disease spectrum because of overlapping genetic, pathological and clinical traits. Changes in serum proteins in FTD and ALS are poorly understood, and currently...
Autores principales: | Katzeff, Jared S., Bright, Fiona, Lo, Kitty, Kril, Jillian J., Connolly, Angela, Crossett, Ben, Ittner, Lars M., Kassiou, Michael, Loy, Clement T., Hodges, John R., Piguet, Olivier, Kiernan, Matthew C., Halliday, Glenda M., Kim, Woojin Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426269/ https://www.ncbi.nlm.nih.gov/pubmed/32792518 http://dx.doi.org/10.1038/s41598-020-70687-7 |
Ejemplares similares
-
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022) -
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
por: Bright, Fiona, et al.
Publicado: (2021) -
Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
por: Werry, Eryn L., et al.
Publicado: (2019) -
Uncovering pathophysiological changes in frontotemporal dementia using serum lipids
por: Phan, Katherine, et al.
Publicado: (2020) -
Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia
por: Lok, Hiu Chuen, et al.
Publicado: (2023)